Real-life rates of treatment completion for HCV

被引：0

作者：

Butt, Adeel A.

Skanderson, Melissa

McGinnis, Kathleen A.

Kwoh, C. K.

Justice, Amy C.

机构：

[1] Univ Pittsburgh, Pittsburgh, PA USA

[2] VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA

[3] VA Connecticut Healthcare Syst, West Haven, CT USA

[4] Yale Univ, Sch Med, New Haven, CT USA

来源：

HEPATOLOGY | 2007年 / 46卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

281

引用

页码：364A / 364A

页数：1

共 50 条

[1] Sofosbuvir as the backbone of treatment for HCV after liver transplantation: a real-life multicenter experience
Satoskar, Rohit
Ahn, Joseph
Te, Helen S.
Deising, Adam
Aronsohn, Andrew
Robertazzi, Suzanne
Schiano, Thomas D.
HEPATOLOGY, 2014, 60 : 537A - 537A
[2] Treatment options for real-life patients
Parker, G
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2004, 8 : 37 - 41
[3] Real-life data on COPD treatment
Karimi, Leila
Baan, Esme J.
Geeraerd, Tiana
Van der Lei, Johan
Stricker, Bruno H. C.
Brusselle, Guy G.
Lahousse, Lies
Verhamme, Katia M.
EUROPEAN RESPIRATORY JOURNAL, 2018, 52
[4] Considerable under-treatment of chronic HCV infection in HIV patients despite acceptable sustained virological response rates in a real-life setting
Reiberger, Thomas
Obermeier, Martin
Payer, Berit A.
Baumgarten, Axel
Weitner, Lutwin
Moll, Arend
Christensen, Stefan
Koeppe, Siegfried
Kundi, Michael
Rieger, Armin
Peck-Radosavljevic, Markus
ANTIVIRAL THERAPY, 2011, 16 (06) : 815 - 824
[5] Fracture rates in patients discontinuing alendronate treatment in real-life: A nationwide cohort study
Darvalics, Bianka
Solling, Anne Sophie
Christensen, Diana H.
Harslof, Torben
Thomsen, Reimar W.
Langdahl, Bente
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 204 - 204
[6] HCV treatment in Sardinian HIV-HCV coinfected patients: a real-life perspective study on safety, efficacy, and immune reconstitution
Pes, Francesco
Onali, Simona
Balestrieri, Cinzia
Angioni, Goffredo
Ortu, Francesco
Piano, Paola
Lucia, Barca
Scioscia, Rosetta
Princic, Elija
Bolliri, Anna Chiara
Casale, Michele
Cola, Alessandra
Conti, Maria
Peddis, Lorenza
Serra, Giancarlo
Vacca, Stefano
Loi, Martina
Urru, Enrico
Murru, Claudia
Matta, Laura
Del Giacco, Stefano
Babudieri, Sergio
Maida, Ivana
Chessa, Luchino
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2022, 20 (11) : 1509 - 1516
[7] Low Treatment Rates and Suboptimal Treatment Completion Rates to Hepatitis C Virus (HCV) Therapy: A Real-World Analysis of a Large US Cohort
Vutien, Philip
Kim, Yoona
Brooks, Louis
Livornese, Richard
Nguyen, Mindie H.
GASTROENTEROLOGY, 2014, 146 (05) : S920 - S920
[8] LOW TREATMENT RATES AND SUBOPTIMAL TREATMENT COMPLETION RATES TO HEPATITIS C VIRUS (HCV) THERAPY: A REAL-WORLD ANALYSIS OF A LARGE US COHORT
Brooks, L. H., Jr.
Schwebke, K.
Livornese, R.
Van Caster, K.
Nguyen, M. H.
JOURNAL OF HEPATOLOGY, 2013, 58 : S363 - S363
[9] Characteristics and retreatment of HCV DAA failure patients: Real-life experience
Ruiz, I.
Fourati, S.
Varaut, A.
Giovanna, S.
Francois, M.
Wlassow, M.
Poiteau, L.
Donati, F.
Soulier, A.
Stephane, C.
Mallat, A.
Pawlotsky, J. -M.
Hezode, C.
JOURNAL OF HEPATOLOGY, 2018, 68 : S277 - S278
[10] Second-generation DAAs for HCV: real-life efficacy in the RESIST-HCV cohort
Cacciola, I.
Petta, S.
Calvaruso, V.
Cartabellotta, F.
Distefano, M.
Scifo, G.
Di Lorenzo, F.
Sanfilippo, A.
Di Rosolini, M. A.
Davi, A.
Benanti, F.
Cacopardo, B.
Licata, A.
Giannitrapani, L.
Cannavo, M. R.
Russello, M.
Madonia, S.
Bavetta, M. G.
Digiacomo, A.
Averna, A.
Alaimo, G.
Larocca, L.
Bertino, G.
Bronte, F.
Guarneri, L.
Scalisi, I.
Iacobello, C.
Colletti, P.
Portelli, V.
Pollicino, T.
Ceccherini-Silberstein, F.
Raimondo, G.
Craxi, A.
Di Marco, V.
DIGESTIVE AND LIVER DISEASE, 2019, 51 : E262 - E263

← 1 2 3 4 5 →